Long-term results (60 months) of anti-VEGF therapy of macular diseases in real clinical practice. Part 1
Purpose: to study long-term (over a 60 months’ follow-up period) results of anti-VEGF therapy for macular diseases in real clinical practice.Materials and methods. We undertook a single-center retrospective uncontrolled cohort study of 169 patients (109 women, 60 men) who received anti-VEGF therapy...
Saved in:
| Main Authors: | E. V. Bobykin, R. V. Buslaev, V. Y. Krokhalev, O. V. Morozova, N. S. Beresneva |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Real Time Ltd
2022-09-01
|
| Series: | Российский офтальмологический журнал |
| Subjects: | |
| Online Access: | https://roj.igb.ru/jour/article/view/1043 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Long-term results (60 months) of anti-VEGF therapy of macular diseases in real clinical practice. Part 2.
by: E. V. Bobykin, et al.
Published: (2022-12-01) -
Factors determining the compliance of patients receiving anti-VEGF therapy for macular diseases with long-term follow-up in real-life practice
by: E. V. Bobykin, et al.
Published: (2021-03-01) -
Metabolomics analysis uncovers metabolic changes and remodeling of anti-VEGF therapy on macular edema
by: Congcong Yan, et al.
Published: (2025-07-01) -
Treatment of macular diseases: an overview of key randomized clinical trials
by: E. V. Bobykin, et al.
Published: (2022-01-01) -
Long-Term Outcomes of Nonadherence to Anti-VEGF Therapy in Advanced Neovascular Age-Related Macular Degeneration
by: A. N. Kulikov, et al.
Published: (2022-10-01)